文献速递免疫规划传染病防控与疫情报告

基于gH-gL融合蛋白的伪狂犬病亚单位疫苗研究

A novel subunit vaccine based on glycoprotein H and glycoprotein L fusion against pseudorabies virus infection.
PubMed 文献 · Vaccine · 2026-05-08

本研究在哺乳动物细胞表达系统中表达伪狂犬病毒(PRV)包膜糖蛋白H(gH)、糖蛋白L(gL)及重组gH-gL融合蛋白,并在小鼠模型中评价其保护效力。gH-gL组中和抗体滴度显著高于其他组,在致死剂量PRV变异株XiangA攻击后存活率达100%,高于gH组(40%)和gL组(50%)。即使在高剂量攻击下,gH-gL组存活率仍为100%,优于商业灭活疫苗组(50%),且组织病毒载量几乎检测不到。

要点

  • gH-gL融合蛋白免疫可诱导高水平中和抗体及Th1/Th2免疫应答。
  • 致死剂量PRV攻击后gH-gL组存活率100%,显著高于gH组和gL组。
  • 高剂量攻击下gH-gL组存活率仍为100%,优于商业灭活疫苗的50%。

核心结论

  • gH-gL重组融合蛋白是防控中国伪狂犬病疫情的候选疫苗。

研究设计与样本

  • 在哺乳动物细胞表达系统中表达gH、gL及gH-gL融合蛋白,并在小鼠模型中评价保护效力。

主要发现

  • gH、gL或gH-gL免疫均诱导特异性中和抗体及Th1/Th2免疫应答,gH-gL组中和抗体滴度显著高于其他组。
  • 2×10^4 TCID50 PRV变异株XiangA攻击后,gH-gL组存活率100%,显著高于gH组(40%)和gL组(50%)。
  • 10^5.5 TCID50高剂量攻击后,gH-gL组存活率仍为100%,优于商业灭活疫苗组(50%)。
  • 攻击后gH-gL组组织病毒载量几乎检测不到,未见明显病理变化。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Pseudorabies (PR) is a highly infectious disease caused by pseudorabies virus (PRV), which leads to significant economic losses. Vaccination remains the most effective method to control PRV infection. To develop an efficient DIVA (differentiation of infected from vaccinated animals) vaccine against PRV, this study expressed the envelope glycoprotein H (gH), glycoprotein L (gL), and a recombinant gH-gL fusion protein in a mammalian cell expression system and evaluated their protective efficacy in a mouse model. Immunization with gH, gL, or gH-gL induced high levels of specific antibodies capable of neutralizing PRV, and elicited a Th1/Th2-mediated immune response. Neutralizing antibody titers in the gH-gL group were significantly higher than those in the other groups. After a lethal challenge with 2 × 104TCID50 of the PRV variant XiangA strain, the survival rate of the gH-gL group was 100%, which was significantly higher than that of the gH (40%) and gL (50%) groups. Even under a higher challenge dose of 105.5TCID50, the survival rate in the gH-gL group remained 100%, outperforming that of mice vaccinated with a commercial inactivated vaccine (50%). Furthermore, after challenge, viral loads in tissues of the gH-gL group were almost undetectable, and no obvious pathological changes were observed. Our results demonstrate that the gH-gL recombinant fusion protein is a promising vaccine candidate for preventing and controlling pseudorabies epidemics in China.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Yu X, Xie S, Luo Y, et al. A novel subunit vaccine based on glycoprotein H and glycoprotein L fusion against pseudorabies virus infection. Vaccine. 2026. PMID: 42105396. doi:10.1016/j.vaccine.2026.128681

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。